We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+11.29%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$1.98B
AUM Growth
+$174M
Cap. Flow
-$16.4M
Cap. Flow %
-0.83%
Top 10 Hldgs %
50.67%
Holding
25
New
–
Increased
21
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$8.95M
2
BDX icon
Becton Dickinson
BDX
+$5.72M
3
CME icon
CME Group
CME
+$1.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.54M
5
ZTS icon
Zoetis
ZTS
+$1.52M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.7M
2
MA icon
Mastercard
MA
+$17.6M
3
TSM icon
TSMC
TSM
+$12.5M
4
WST icon
West Pharmaceutical
WST
+$6.22M

Sector Composition

Rank Sector Weight
1 Technology 22.99%
2 Financials 20.96%
3 Communication Services 20.48%
4 Healthcare 20.04%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
1
Mastercard
MA
$477B
$109M 5.52%
365,421
-62,596
-15% -$17.6M
AAPL icon
2
Apple
AAPL
$4.89T
$105M 5.33%
1,433,824
-274,932
-16% -$17.7M
TSM icon
3
TSMC
TSM
$2.09T
$103M 5.19%
1,765,960
-236,419
-12% -$12.5M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.9T
$101M 5.09%
1,504,040
+23,860
+2% +$1.54M
ZTS icon
5
Zoetis
ZTS
$31.6B
$100M 5.08%
758,394
+12,230
+2% +$1.52M
BABA icon
6
Alibaba
BABA
$269B
$97.9M 4.95%
461,365
+7,474
+2% +$1.4M
SCHW
7
Charles Schwab
SCHW
$177B
$97.5M 4.94%
2,050,312
+33,219
+2% +$1.46M
CME icon
8
CME Group
CME
$92.2B
$97.2M 4.92%
484,211
+7,797
+2% +$1.6M
META icon
9
Meta Platforms (Facebook)
META
$1.51T
$95.8M 4.85%
466,727
+7,443
+2% +$1.44M
SPGI icon
10
S&P Global
SPGI
$126B
$94.6M 4.79%
346,399
+5,732
+2% +$1.49M
CMCSA icon
11
Comcast
CMCSA
$79.1B
$93.4M 4.73%
2,077,638
+33,454
+2% +$1.49M
FIS icon
12
Fidelity National Information Services
FIS
$21.5B
$90.6M 4.59%
651,509
+10,614
+2% +$1.42M
DHR icon
13
Danaher
DHR
$135B
$88.8M 4.5%
652,606
+10,612
+2% +$1.34M
ALLE icon
14
Allegion
ALLE
$13B
$87.9M 4.45%
705,556
+11,501
+2% +$1.33M
BDX icon
15
Becton Dickinson
BDX
$43.1B
$87.2M 4.41%
328,486
+22,961
+8% +$5.72M
ANSS
16
DELISTED
Ansys
ANSS
$84.2M 4.26%
327,202
+4,710
+1% +$1.11M
BIO icon
17
Bio-Rad Laboratories Class A
BIO
$8.42B
$81.5M 4.12%
220,201
+25,391
+13% +$8.95M
ACN icon
18
Accenture
ACN
$89.9B
$71.4M 3.61%
338,979
+5,442
+2% +$1.06M
EA icon
19
Electronic Arts
EA
$52.4B
$65.5M 3.31%
608,826
+9,747
+2% +$968K
TV icon
20
Televisa
TV
$1.45B
$49.4M 2.5%
4,210,541
+67,826
+2% +$751K
ECL icon
21
Ecolab
ECL
$75.6B
$45.1M 2.28%
233,525
+3,779
+2% +$717K
CL icon
22
Colgate-Palmolive
CL
$72.6B
$41.5M 2.1%
602,245
+9,777
+2% +$667K
WST icon
23
West Pharmaceutical
WST
$23.1B
$38M 1.92%
252,665
-42,691
-14% -$6.22M
WBT
24
DELISTED
Welbilt, Inc.
WBT
$34.6M 1.75%
2,214,668
+35,404
+2% +$606K
HDB icon
25
HDFC Bank
HDB
$119B
$15.7M 0.79%
494,294
+34,474
+7% +$1.05M

Similar funds

CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return

Intermede Investment Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Intermede Investment Partners held 25 positions worth $1.98B, up 9.7% from $1.8B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 0%. Intermede Investment Partners opened no new positions and made no exits, leaving the 25-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

  • Intermede Investment Partners added most to Bio-Rad Laboratories Class A in Q4 2019, an estimated $8.95M increase.
  • Intermede Investment Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $17.7M.
  • Intermede Investment Partners's ten largest holdings make up 51% of its $1.98B portfolio in Q4 2019.
  • Intermede Investment Partners opened 0 new positions and closed 0 in Q4 2019.
  • Intermede Investment Partners's portfolio value rose 9.7% quarter-over-quarter to $1.98B.

Based on Intermede Investment Partners's 13F filing for Q4 2019, filed 10 Feb 2020.